|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-6-22
|
|
pubmed:abstractText |
Asymmetric dimethylarginine (ADMA) has raised considerable interest, as it is an endogenous inhibitor of nitric oxide synthesis. While increased plasma levels of ADMA have been reported in different cardiovascular disease states, its association with symmetric dimethylarginine (SDMA) has not been evaluated in a prospective population-based study.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1879-1484
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
205
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
261-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19100547-Adult,
pubmed-meshheading:19100547-Aged,
pubmed-meshheading:19100547-Arginine,
pubmed-meshheading:19100547-Cardiovascular Diseases,
pubmed-meshheading:19100547-Cohort Studies,
pubmed-meshheading:19100547-Female,
pubmed-meshheading:19100547-Humans,
pubmed-meshheading:19100547-Male,
pubmed-meshheading:19100547-Mass Spectrometry,
pubmed-meshheading:19100547-Middle Aged,
pubmed-meshheading:19100547-Nitric Oxide,
pubmed-meshheading:19100547-Proportional Hazards Models,
pubmed-meshheading:19100547-Prospective Studies,
pubmed-meshheading:19100547-Risk
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population.
|
|
pubmed:affiliation |
Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
